JP2019510482A5 - - Google Patents

Download PDF

Info

Publication number
JP2019510482A5
JP2019510482A5 JP2018544785A JP2018544785A JP2019510482A5 JP 2019510482 A5 JP2019510482 A5 JP 2019510482A5 JP 2018544785 A JP2018544785 A JP 2018544785A JP 2018544785 A JP2018544785 A JP 2018544785A JP 2019510482 A5 JP2019510482 A5 JP 2019510482A5
Authority
JP
Japan
Prior art keywords
cells
methods
derived
culture medium
beta cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018544785A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019510482A (ja
JP7123802B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2017/054390 external-priority patent/WO2017144695A1/en
Publication of JP2019510482A publication Critical patent/JP2019510482A/ja
Publication of JP2019510482A5 publication Critical patent/JP2019510482A5/ja
Application granted granted Critical
Publication of JP7123802B2 publication Critical patent/JP7123802B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018544785A 2016-02-24 2017-02-24 ヒト多能性幹細胞由来内分泌前駆細胞からの機能的ベータ細胞の産生 Active JP7123802B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP16157181 2016-02-24
EP16157181.5 2016-02-24
PCT/EP2017/054390 WO2017144695A1 (en) 2016-02-24 2017-02-24 Generation of functional beta cells from human pluripotent stem cell-derived endocrine progenitors

Publications (3)

Publication Number Publication Date
JP2019510482A JP2019510482A (ja) 2019-04-18
JP2019510482A5 true JP2019510482A5 (enExample) 2020-04-02
JP7123802B2 JP7123802B2 (ja) 2022-08-23

Family

ID=55588039

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018544785A Active JP7123802B2 (ja) 2016-02-24 2017-02-24 ヒト多能性幹細胞由来内分泌前駆細胞からの機能的ベータ細胞の産生

Country Status (7)

Country Link
US (1) US11274280B2 (enExample)
EP (1) EP3420073B1 (enExample)
JP (1) JP7123802B2 (enExample)
CN (1) CN108699515A (enExample)
ES (1) ES2967942T3 (enExample)
MA (1) MA45747A (enExample)
WO (1) WO2017144695A1 (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2705001C2 (ru) 2011-12-22 2019-11-01 Янссен Байотек, Инк. Дифференцировка эмбриональных стволовых клеток человека в одногормональные инсулинположительные клетки
AU2014278178B2 (en) 2013-06-11 2021-01-21 President And Fellows Of Harvard College SC-beta cells and compositions and methods for generating the same
SG11201609473XA (en) 2014-05-16 2016-12-29 Janssen Biotech Inc Use of small molecules to enhance mafa expression in pancreatic endocrine cells
CN107614678B (zh) 2014-12-18 2021-04-30 哈佛学院校长同事会 干细胞来源的β细胞的产生方法及其使用方法
EP3420073B1 (en) 2016-02-24 2023-11-08 Novo Nordisk A/S Generation of functional beta cells from human pluripotent stem cell-derived endocrine progenitors
CA3027879A1 (en) * 2016-06-21 2017-12-28 Janssen Biotech, Inc. Generation of human pluripotent stem cell derived functional beta cells showing a glucose-dependent mitochondrial respiration and two-phase insulin secretion response
SG11202001906PA (en) 2017-09-11 2020-04-29 Novo Nordisk As Enrichment of nkx6.1 and c-peptide co-expressing cells derived in vitro from stem cells
WO2019099725A1 (en) 2017-11-15 2019-05-23 Semma Therapeutics, Inc. Islet cell manufacturing compositions and methods of use
WO2019169351A1 (en) 2018-03-02 2019-09-06 Semma Therapeutics, Inc. Methods of enhancing stem cell differentiation into beta cells
EP3833365A4 (en) 2018-08-10 2022-05-11 Vertex Pharmaceuticals Incorporated Stem cell derived islet differentiation
AU2018439389A1 (en) * 2018-08-30 2021-02-18 Novo Nordisk A/S Generation of functional beta cells from human pluripotent stem cell-derived endocrine progenitors
EP3953451A1 (en) 2019-04-08 2022-02-16 Novo Nordisk A/S Generation of pancreatic endoderm from stem cell derived definitive endoderm
TW202115245A (zh) 2019-06-27 2021-04-16 丹麥商諾佛 儂迪克股份有限公司 安全免疫隱形細胞
JP2023503302A (ja) 2019-11-22 2023-01-27 ノヴォ ノルディスク アー/エス スピン凝集した神経系マイクロスフェアおよびその応用
WO2021174201A1 (en) * 2020-02-28 2021-09-02 The Trustees Of The University Of Pennsylvania Tissue culture media for survival and engraftment of human pancreatic islets
US20230340595A1 (en) 2020-03-02 2023-10-26 Novo Nordisk A/S Use of pluripotent markers to detect contaminating residual undifferentiated pluripotent stem cells
WO2022043518A1 (en) 2020-08-28 2022-03-03 Novo Nordisk A/S Method for screening in vitro population of stem cell derived beta like cells and novel markers thereof
WO2022129472A1 (en) 2020-12-18 2022-06-23 Novo Nordisk A/S Safe immuno-stealth cells
WO2022136215A1 (en) 2020-12-21 2022-06-30 Novo Nordisk A/S Safe immuno-stealth cells
CN113069440A (zh) * 2021-04-08 2021-07-06 澳门大学 甲状腺素的新的应用、培养多能干细胞的方法和培养基
CA3236375A1 (en) * 2021-10-28 2023-05-04 Lorenz Studer Compositions and methods for promoting in vitro maturation of cells
WO2023118050A1 (en) 2021-12-21 2023-06-29 Novo Nordisk A/S Use of novel markers to detect pluripotent stem cells
WO2024151541A1 (en) 2023-01-09 2024-07-18 Sana Biotechnology, Inc. Type-1 diabetes autoimmune mouse
WO2024243236A2 (en) 2023-05-22 2024-11-28 Sana Biotechnology, Inc. Methods of delivery of islet cells and related methods
WO2025093467A1 (en) 2023-10-31 2025-05-08 Novo Nordisk A/S Methods for preventing unwanted cells arising during differentiation of human pluripotent stem cells

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2516625T3 (da) 2009-12-23 2024-09-09 Janssen Biotech Inc Differentiering af humane embryonale stamceller
AU2011250912A1 (en) 2010-05-12 2012-11-22 Janssen Biotech, Inc. Differentiation of human embryonic stem cells
WO2012175633A1 (en) 2011-06-21 2012-12-27 Novo Nordisk A/S Efficient induction of definitive endoderm from pluripotent stem cells
DK2844739T3 (da) * 2012-04-30 2019-09-30 Univ Health Network FREMGANGSMÅDER OG SAMMENSÆTNINGER TIL GENERERING AF PANCREATISKE PROGENITORER OG FUNKTIONELLE BETA-CELLER UD FRA hPSC'ER
EP2893000B1 (en) * 2012-09-03 2019-04-10 Novo Nordisk A/S Generation of pancreatic endoderm from pluripotent stem cells using small molecules
US9708608B2 (en) * 2012-09-27 2017-07-18 Institut National De La Sante Et De La Recherche Medicale (Inserm) Methods for producing a population of pancreatic beta-cells
MX2015008578A (es) 2012-12-31 2015-09-07 Janssen Biotech Inc Diferenciacion de celulas madre embrionarias humanas en celulas endocrinas pancreaticas mediante el uso de relugadores de hb9.
US20150368616A1 (en) * 2013-02-14 2015-12-24 The Cleveland Clinic Foundation Methods for induction of cell fates from pluripotent cells
CN105531365A (zh) 2013-04-23 2016-04-27 耶达研究及发展有限公司 分离的幼稚多能干细胞和产生所述细胞的方法
WO2014179198A1 (en) 2013-04-29 2014-11-06 Wisconsin Alumni Research Foundation Methods for producing insulin-secreting beta cells from human pluripotent stem cells
AU2014278178B2 (en) 2013-06-11 2021-01-21 President And Fellows Of Harvard College SC-beta cells and compositions and methods for generating the same
DK3039122T3 (da) 2013-08-30 2019-09-30 Novo Nordisk As Generering af endokrine progenitorceller fra humane pluripotente stamceller under anvendelse af små molekyler
US20150250824A1 (en) * 2014-03-07 2015-09-10 The Research Foundation For The State University Of New York Methods and compositions for expansion of stem cells and other cells
SG11201609473XA (en) 2014-05-16 2016-12-29 Janssen Biotech Inc Use of small molecules to enhance mafa expression in pancreatic endocrine cells
EP3420073B1 (en) 2016-02-24 2023-11-08 Novo Nordisk A/S Generation of functional beta cells from human pluripotent stem cell-derived endocrine progenitors
AU2018439389A1 (en) 2018-08-30 2021-02-18 Novo Nordisk A/S Generation of functional beta cells from human pluripotent stem cell-derived endocrine progenitors

Similar Documents

Publication Publication Date Title
RU2019101200A (ru) Генерация функциональных бета-клеток, полученных из человеческой плюрипотентной стволовой клетки, демонстрирующих реакцию в виде глюкозозависимого митохондриального дыхания и двухфазной секреции инсулина
RU2012131400A (ru) Дифференцировка человеческих эмбриональных стволовых клеток
JP2019103521A5 (enExample)
ZA202309671B (en) Methods and compositions for generating chondrocyte lineage cells and/or cartilage like tissue
AU2017254264A1 (en) Method for producing retinal tissue
JP2019518465A5 (enExample)
JP2017515507A5 (enExample)
MY177268A (en) Medium system and method for ex vivo expansion of nk cells
NZ703888A (en) Methods of generating natural killer cells
NZ709124A (en) Multipotent stem cells from the extrahepatic biliary tree and methods of isolating same
MX2020005907A (es) Formulacion de medio libre de suero para cultivar celulas y metodos de uso de la misma.
WO2016168890A8 (en) Generation of muscle-lineage cells from stem cells
NZ759164A (en) Liver organoid compositions and methods of making and using same
EP2408903A4 (en) PLURIPOTENTE AND MULTIPOTENTE CELL CULTURE ON MICROWAVES
JP2016513972A5 (enExample)
PH12012501254A1 (en) Differentiation of human embryonic stem cells
JP2015061520A5 (enExample)
AR094347A1 (es) Cultivo de células madre embrionarias humanas en la interfase aire-líquido para la diferenciación en células endocrinas pancreáticas
RU2012105924A (ru) Дифференцировка эмбриональных стволовых клеток человека
ES2967942T3 (es) Generación de células beta funcionales a partir de progenitoras endocrinas derivadas de células madre pluripotentes humanas
JP2013536687A5 (enExample)
AR100446A1 (es) Uso de moléculas pequeñas para mejorar la expresión de mafa en células endócrinas pancreáticas
SE0850111L (sv) Förfarande för differentiering av stamceller till celler av den endodermala och pankreatiska utvecklingslinjen
BR112015022770A8 (pt) meio e sistema de cultivo da célula livre de xenógeno, livre de albumina, forma concentrada, métodos de diferenciação de células-tronco pluripotentes humanas, para a produção de mesenquimoangioblastos e sistema definido de cultivo da célula para diferenciação hematoendotelial das células- tronco pluripotentes humanas
BRPI0617378B8 (pt) Uso de um inibidor de il-6 para produzir uma composição farmacêutica para suprimir dano a um ilhota transplantada depois do transplante de ilhota; e aperfeiçoar a viabilidade de uma ilhota em um transplante de ilhota